Mangoceuticals, Inc. (NASDAQ:MGRX) Shares Shorted: Short Interest Down 41.7% in October

Mangoceuticals, Inc. (NASDAQ:MGRX – Get Free Report) was the recipient of a large decline in short interest in October. As of October 30th, there was short interest totaling 53,343 shares, a decline of 41.7% from the October 15th total of 91,564 shares. Based on an average daily trading volume, of 369,429 shares, the short-interest ratio is currently 0.1 days. Approximately 0.3% of the company’s stock are sold short.

Analyst Ratings Changes

Several research firms recently weighed in on MGRX. Weiss Ratings restated a “sell (e+)” rating on shares of Mangoceuticals in a research note on Monday, September 21st. Wall Street Zen raised Mangoceuticals to a “sell” rating in a research report on Saturday, July 25th. One research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Report on MGRX

Mangoceuticals Trading Down 1.3%

MGRX opened at $0.16 on Wednesday. The company has a market cap of $3.41 million, a price-to-earnings ratio of -0.31 and a beta of 2.15. The company’s 50 day moving average is $0.33 and its 200 day moving average is $0.39. Mangoceuticals has a 12-month low of $0.15 and a 12-month high of $1.38.

Mangoceuticals (NASDAQ:MGRX – Get Free Report) last announced its earnings results on Monday, November 16th. The company reported ($0.19) EPS for the quarter. Mangoceuticals had a negative net margin of 3,679.33% and a negative return on equity of 68.23%. The business had revenue of $0.07 million for the quarter.

Mangoceuticals Company Profile

(Get Free Report)

Mangoceuticals, Inc. is a men’s health and wellness company that offers telehealth services through its online platform. The platform connects customers with healthcare providers for consultations and, when appropriate, prescription treatments. The company’s offerings have included treatments for erectile dysfunction, hair loss and testosterone-related concerns, as well as weight-management services. Prescriptions are fulfilled through pharmacy partners. Mangoceuticals primarily serves customers in the United States through its digital platform.

Featured Stories

Receive News & Ratings for Mangoceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mangoceuticals and related companies with MarketBeat.com's FREE daily email newsletter.